Willie Quinn | Chief Financial Officer & Senior Vice President, Corporate Development |
Dayton Misfeldt | Interim Chief Executive Officer |
Judy Fox | Chief Scientific Officer |
Deepali Suri | Vice President, Clinical Operations |
Marc Frahm | Cowen and Company |
Hartaj Singh | Oppenheimer |
Good afternoon, ladies and gentlemen and welcome to the Q1 2019 Sunesis Pharmaceuticals Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded.